health biotech news today obesity drugs glp-1 Novartis, Alector, Merck, Alnylm, UniQure : Readout Newsletter GLP-1 Agonists Weight Loss Drugs

Continued treatment with tirzepatide for maintenance of weight reduction in adults with obesity: the surmount-4 randomized clinical trial

Sodium-Glucose Cotransporter-2 Inhibition for the Reduction of Cardiovascular Events in High-Risk Patients with Diabetes Mellitus

CONCLUSION Although more research and consensus are needed to determine the optimal length of time for holding GLP-1 receptor agonists before a procedure requiring anesthesia, it is important for practitioners and patients to be aware of the increased risks for aspiration and to consider strategies to mitigate harm

These might include any decline in infant weight gain percentile

"The Wegovy pill is the most recent example of Novo Nordisk's decades-long commitment to obesity treatment

Saxenda for Weight Loss: What You Need to Know A comprehensive guide to Saxenda (liraglutide) for weight loss Saxenda (liraglutide) is among the growing list of diabetes medications being used for weight loss